Recap: ACADIA Pharmaceuticals Q4 Earnings

ACADIA Pharmaceuticals ACAD reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

ACADIA Pharmaceuticals missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.28 versus an estimate of $0.3.

Revenue was up $94.55 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 5.0% increase in the share price the next day.

Here's a look at ACADIA Pharmaceuticals's past performance:

To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.